Harnessing Natural Products by a Pharmacophore-Oriented Semisynthesis Approach for the Discovery of Potential Anti-SARS-CoV-2 Agents

被引:10
作者
Zhou, Yuan-Fei [1 ,2 ]
Yan, Bing-Chao [1 ,2 ]
Yang, Qian [1 ,2 ]
Long, Xin-Yan [3 ]
Zhang, Dan-Qi [4 ,5 ]
Luo, Rong-Hua [3 ]
Wang, Han-Yu [1 ,2 ]
Sun, Han-Dong [1 ,2 ]
Xue, Xiao-Song [4 ,5 ]
Zheng, Yong-Tang [3 ]
Puno, Pema-Tenzin [1 ,2 ]
机构
[1] Chinese Acad Sci, Univ Chinese Acad Sci, Kunming Inst Bot, State Key Lab Phytochem & Plant Resources West Ch, Kunming 650201, Yunnan, Peoples R China
[2] Chinese Acad Sci, Univ Chinese Acad Sci, Kunming Inst Bot, Yunnan Key Lab Nat Med Chem, Kunming 650201, Yunnan, Peoples R China
[3] Chinese Acad Sci, Key Lab Anim Models & Human Dis Mech, Kunming Inst Zool, Kunming 650223, Yunnan, Peoples R China
[4] Nankai Univ, Coll Chem, State Key Lab Elementoorgan Chem, Tianjin 300071, Peoples R China
[5] Chinese Acad Sci, Univ Chinese Acad Sci, Shanghai Inst Organ Chem, Key Lab Organofluorine Chem, 345 Lingling Rd, Shanghai 200032, Peoples R China
基金
中国博士后科学基金; 中国国家自然科学基金;
关键词
Anti-SARS-CoV-2; Agents; Domino Reactions; Natural Products; Semisynthesis; Wolff Rearrangement; ORIDONIN; STRATEGY; ANALOGS;
D O I
10.1002/anie.202201684
中图分类号
O6 [化学];
学科分类号
0703 ;
摘要
Natural products possessing unique scaffolds may have antiviral activity but their complex structures hinder facile synthesis. A pharmacophore-oriented semisynthesis approach was applied to (-)-maoelactone A (1) and oridonin (2) for the discovery of anti-SARS-CoV-2 agents. The Wolff rearrangement/lactonization cascade (WRLC) reaction was developed to construct the unprecedented maoelactone-type scaffold during semisynthesis of 1. Further mechanistic study suggested a concerted mechanism for Wolff rearrangement and a water-assisted stepwise process for lactonization. The WRLC reaction then enabled the creation of a novel family by assembly of the maoelactone-type scaffold and the pharmacophore of 2, whereby one derivative inhibited SARS-CoV-2 replication in HPA EpiC cells with a low EC50 value (19 +/- 1 nM) and a high TI value (>1000), both values better than those of remdesivir.
引用
收藏
页数:9
相关论文
共 57 条
[1]   Simplified immunosuppressive and neuroprotective agents based on gracilin A [J].
Abbasov, Mikail E. ;
Alvarino, Rebeca ;
Chaheine, Christian M. ;
Alonso, Eva ;
Sanchez, Jon A. ;
Conner, Michael L. ;
Alfonso, Amparo ;
Jaspars, Marcel ;
Botana, Luis M. ;
Romo, Daniel .
NATURE CHEMISTRY, 2019, 11 (04) :342-350
[2]  
[Anonymous], 2011, ANGEW CHEM, V123, P10990, DOI DOI 10.1039/C7RA10716A
[3]   Finding the missing heritability of complex diseases [J].
Manolio, Teri A. ;
Collins, Francis S. ;
Cox, Nancy J. ;
Goldstein, David B. ;
Hindorff, Lucia A. ;
Hunter, David J. ;
McCarthy, Mark I. ;
Ramos, Erin M. ;
Cardon, Lon R. ;
Chakravarti, Aravinda ;
Cho, Judy H. ;
Guttmacher, Alan E. ;
Kong, Augustine ;
Kruglyak, Leonid ;
Mardis, Elaine ;
Rotimi, Charles N. ;
Slatkin, Montgomery ;
Valle, David ;
Whittemore, Alice S. ;
Boehnke, Michael ;
Clark, Andrew G. ;
Eichler, Evan E. ;
Gibson, Greg ;
Haines, Jonathan L. ;
Mackay, Trudy F. C. ;
McCarroll, Steven A. ;
Visscher, Peter M. .
NATURE, 2009, 461 (7265) :747-753
[4]  
[Anonymous], British Medical Journal
[5]   Concise asymmetric synthesis of (-)-bilobalide [J].
Baker, Meghan A. ;
Demoret, Robert M. ;
Ohtawa, Masaki ;
Shenvi, Ryan A. .
NATURE, 2019, 575 (7784) :643-+
[6]   A planning strategy for diversity-oriented synthesis [J].
Burke, MD ;
Schreiber, SL .
ANGEWANDTE CHEMIE-INTERNATIONAL EDITION, 2004, 43 (01) :46-58
[7]   11-Step Total Synthesis of (-)-Maoecrystal V [J].
Cernijenko, Artiom ;
Risgaard, Rune ;
Baran, Phil S. .
JOURNAL OF THE AMERICAN CHEMICAL SOCIETY, 2016, 138 (30) :9425-9428
[8]   Synthesis and biological evaluation of caracasine acid derivatives [J].
Chavez, Katiuska ;
Compagnone, Reinaldo S. ;
Alvarez, Annamil ;
Figarella, Katherine ;
Galindo-Castro, Ivan ;
Marsiccobetre, Sabrina ;
Trivino, Jennifer ;
Arocha, Irina ;
Taddei, Antonieta ;
Orsini, Giovannina ;
Tillett, Stephen ;
Suarez, Alirica I. .
BIOORGANIC & MEDICINAL CHEMISTRY, 2015, 23 (13) :3687-3695
[9]   A tale of two antiviral targets - and the COVID-19 drugs that bind them [J].
Cully, Megan .
NATURE REVIEWS DRUG DISCOVERY, 2022, 21 (01) :3-5
[10]   Structure-based design of antiviral drug candidates targeting the SARS-CoV-2 main protease [J].
Dai, Wenhao ;
Zhang, Bing ;
Jiang, Xia-Ming ;
Su, Haixia ;
Li, Jian ;
Zhao, Yao ;
Xie, Xiong ;
Jin, Zhenming ;
Peng, Jingjing ;
Liu, Fengjiang ;
Li, Chunpu ;
Li, You ;
Bai, Fang ;
Wang, Haofeng ;
Cheng, Xi ;
Cen, Xiaobo ;
Hu, Shulei ;
Yang, Xiuna ;
Wang, Jiang ;
Liu, Xiang ;
Xiao, Gengfu ;
Jiang, Hualiang ;
Rao, Zihe ;
Zhang, Lei-Ke ;
Xu, Yechun ;
Yang, Haitao ;
Liu, Hong .
SCIENCE, 2020, 368 (6497) :1331-+